Clinical trial

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or…

NCT00296361 · Astellas Pharma Inc, Industry · Completed

Key facts

NCT number NCT00296361
Title To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.
Official title A Multicentre, Randomised, Open Clinical Study to Compare the Efficacy and Safety of a Combination Therapy of Tacrolimus With Sirolimus Versus Tacrolimus With Mycophenolate Mofetil in Kidney Transplantation.
Acronym RESTORE
Lead sponsor Astellas Pharma Inc, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Kidney Transplantation
Intervention type Drug
Interventions Tacrolimus
Enrollment 634
Start date Oct 1, 2004
Primary completion Jul 1, 2006
Completion Jul 1, 2006
First posted Feb 27, 2006
Last update posted Sep 1, 2014
Countries Australia, Austria, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Spain and 2 more

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies